Peijia Medical received the NMPA approval for the registration application of TaurusMaxTM in August 14, 2024. TaurusMaxTM is an iteration of TaurusElite®, with the following advantages:
1) Commissural Alignment: ensuring proper alignment of the commissures to protect the coronary artery pathways, safeguarding the patients’ entire life cycle;
2) Vision+ Marker: a clear visualization ring at the base for accurate judgment of implantation depth; 3) A2 FlexTM Dual-Axis Bending: optimizing coaxiality for precise implantation.
Medical device name: TaurusMax® Transcatheter Aortic Valve Replacement System
Medical device manufacturer: Peijia Medical Technology (Suzhou) Co., Ltd.
Medical device registration certificate No.: GXZZ 20243131477
